| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9974853 | The Journal of Heart and Lung Transplantation | 2005 | 8 Pages |
Abstract
Percutaneous, transvascular, direct intramyocardial bone marrow cell transplantation is safe and feasible in chronically infarcted tissue. In this pilot study, cell therapy improved overall left ventricular systolic function by recruiting previously hypokinetic or akinetic myocardial tissue.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Craig A. MD, MMSc, Vivek K. MD, Ashok PhD, Stuart MD, Motoya MD, Andre MD, Eugene MD, PhD, Joseph P. MD, Herman K. MD,